The content on this site is intended for healthcare professionals only
Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Nivolumab plus chemotherapy or ipilimumab vs chemotherapy as first-line treatmen...
Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
14 Oct 2021
Pathogenesis of colon adenocarcinoma in Kerala, India
Dr Prasanth Ariyannur - Amrita Institute of Medical Sciences and Research Center...
12 Oct 2021
ESMO 2021: Latest in EGFR mutated advanced NSCLC
Dr Anna Minchom, Prof Natasha Leighl, Dr Victor Moreno and Dr Carlos Cabrera
11 Oct 2021
First-line nivolumab + ipilimumab + chemo in patients with advanced NSCLC and br...
Dr David Paul Carbone - The Ohio State University Medical Center, Ohio, USA
6 Oct 2021
Trastuzumab deruxtecan vs trastuzumab emtansine in patients with HER2+ metastati...
Dr Javier Cortés - Hospital Universitario Ramón y Cajal, Madrid, Spain
30 Sep 2021
ESMO 2021: PARPi data and their role in mono/combination therapies
Dr Neal Shore, Prof Fred Saad, Prof Eleni Efstathiou, Prof Andrew Armstrong
29 Sep 2021
Radioembolisation with chemotherapy for colorectal liver metastases
Dr Mary Mulcahy - Northwestern Memorial Hospital, Chicago, USA
28 Sep 2021
ESMO 2021: Breast cancer roundup
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
27 Sep 2021
[Vic-]trastuzumab duocarmazine shows improved PFS in pre-treated HER2+ locally a...
Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain
![[Vic-]trastuzumab duocarmazine shows improved PFS in pre-treated HER2+ locally advanced or metastatic breast cancer ( Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain )](https://cdn.ecancer.org/42950-m.jpg "[Vic-]trastuzumab duocarmazine shows improved PFS in pre-treated HER2+ locally advanced or metastatic breast cancer ( Dr Cristina Saura - Vall d’Hebron University Hospital, Barcelona, Spain )")
24 Sep 2021
Enzalutamide plus androgen deprivation therapy prolongs survival in men with met...
Prof Andrew Armstrong - Duke University, Durham, USA
24 Sep 2021
Advances in prostate cancer in the last 10 years and a glimpse to the future
Prof Laura-Maria Krabbe, Prof Karim Fizazi and Prof Johann De Bono
24 Sep 2021
Acetylsalicylic acid added to atezolizumab bevacizumab combo does not improve ef...
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
24 Sep 2021
